|
Deciphera Pharmaceuticals Inc (NASDAQ: DCPH) |
|
Deciphera Pharmaceuticals Inc
DCPH's Fundamental analysis
Select the Comparisons :
|
|
Select the Ratio:
|
|
|
Looking into Deciphera Pharmaceuticals Inc growth rates, revenue grew
by 34.55 % in I. Quarter 2024 from the same quarter a year ago.
Ranking at No. 439
Major Pharmaceutical Preparations industry recorded
growth of revenues by 0.35 %
Deciphera Pharmaceuticals Inc net loss decreased from $-50 millions, to $-45 millions in I. Quarter 2024,
• More on DCPH's Growth
|
|
Deciphera Pharmaceuticals Inc realized a net loss in trailing twelve months.
Deciphera Pharmaceuticals Inc realized cash reduction of $ -0.27 per share in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Company's Price to Sales ratio is at 12.79.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.42.
• More on DCPH's Valuation
|
|
|
|
|
Deciphera Pharmaceuticals Inc realized net loss in trailing twelve months.
Deciphera Pharmaceuticals Inc realized cash outflow of $ -0.27per share in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Company's Price to Sales ratio is at 12.79.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.42.
Deciphera Pharmaceuticals Inc Price to Book Ratio is at 7.08 lower than Industry Avg. of 88.33. and higher than S&P 500 Avg. of 0.02
• More on DCPH's Valuation
|
|
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2025 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com